Moleculin Biotech Inc (NASDAQ:MBRX)’s traded shares stood at 2.82 million during the last session, with the company’s beta value hitting 1.30. At the close of trading, the stock’s price was $0.35, to imply an increase of 7.09% or $0.03 in intraday trading. The MBRX share’s 52-week high remains $4.71, putting it -1245.71% down since that peak but still an impressive 28.57% since price per share fell to its 52-week low of $0.25. The company has a valuation of $8.37M, with an average of 9.53 million shares in intraday trading volume over the past 10 days and average of 1.99 million shares over the past 3 months.
Moleculin Biotech Inc (NASDAQ:MBRX) trade information
After registering a 7.09% upside in the last session, Moleculin Biotech Inc (MBRX) has traded red over the past five days. The 5-day price performance for the stock is 17.96%, and -61.81% over 30 days. With these gigs, the year-to-date price performance is -90.13%. Short interest in Moleculin Biotech Inc (NASDAQ:MBRX) saw shorts transact 1.93 million shares and set a 2.21 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 26.36% for the past 5-year period. While 2025 is set for a 75.21% return in earnings, projections for the next 5 years are at 42.60% annually.
MBRX Dividends
Moleculin Biotech Inc has its next earnings report out on 2025-May-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders
Moleculin Biotech Inc insiders hold 4.42% of total outstanding shares, with institutional holders owning 6.13% of the shares at 6.42% float percentage. In total, 6.13% institutions holds shares in the company, led by ARMISTICE CAPITAL, LLC. As of 2024-06-30, the company held over 0.16 million shares (or 6.1339% of shares), all amounting to roughly $0.55 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 84418.0 shares, or about 3.3193% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.3 million.
We also have VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Moleculin Biotech Inc (MBRX) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund holds roughly 30.31 shares. This is just over 0.21% of the total shares, with a market valuation of $10534.0. Data from the same date shows that the other fund manager holds a little less at 18.49, or 0.13% of the shares, all valued at about 6425.0.
